YOLFTbeta
China National Accord Medicines Corp Ltd

China National Accord Medicines Corp Ltd

200028 · SHE · Healthcare / Medical Distribution

12.80HKD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close12.80
Open12.92
Day Range12.77 – 12.92
52-Week Range11.31 – 12.12
Volume156.90K
Market Cap7.33B
P/E (TTM)5.84
Forward P/E6.84
EPS2.05
Dividend Yield5.89%
Beta0.10
50-Day Avg11.97
200-Day Avg12.31

About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and health products. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. China National Accord Medicines Corporation Ltd. was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Guolin Gu
  • Employees0
  • HeadquartersYizhi Pharmaceutical Building, Shenzhen, China, 518029, China
  • Websitehttps://www.szaccord.com.cn

Leadership

  • Mr. Guolin GuDeputy GM, CFO, General Counsel & Chief Compliance Officer · b. 1976
  • Mr. Chuan LiDeputy GM & Board Secretary · b. 1977
  • Mr. Jinxiong LiGM & Non-Independent Director · b. 1979
  • Xuefei WangAccounting Supervisor

Financials

Income Statement

Currency: CNY1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue62.38M84.52M119.46M128.90M161.20M151.69M84.62M88.44M90.19M107.90M1.67B1.87B1.78B1.58B1.64B5.67B6.88B8.36B10.95B13.06B15.13B18.01B21.20B23.95B37.82B41.25B41.26B43.12B52.79B59.65B68.36B73.44B75.48B74.38B71.52B
Growth (%)-+35.48%+41.34%+7.89%+25.06%-5.90%-44.22%+4.51%+1.98%+19.64%+1446.52%+12.06%-4.76%-11.50%+3.77%+246.52%+21.36%+21.55%+30.97%+19.31%+15.81%+19.04%+17.70%+12.99%+57.88%+9.07%+0.04%+4.51%+22.41%+13.00%+14.60%+7.44%+2.77%-1.46%-3.85%
Cost of Revenue-42.26M55.53M74.34M103.53M89.11M57.38M62.56M55.26M69.44M1.21B1.46B1.35B1.20B1.26B5.09B6.17B7.63B10.02B11.93B13.80B16.43B19.47B22.02B33.46B36.66B36.82B38.04B46.92B52.62B60.37B64.56B66.47B66.18B65.58B
Gross Profit62.38M42.26M63.93M54.56M57.67M62.58M27.24M25.88M34.93M38.46M462.34M413.41M431.69M373.25M373.15M581.63M707.10M732.54M928.65M1.14B1.33B1.58B1.73B1.93B4.36B4.59B4.44B5.08B5.87B7.03B7.99B8.88B9.01B8.20B7.84B
Gross Margin100.00%50.00%53.52%42.33%35.77%41.25%32.19%29.26%38.73%35.64%27.71%22.11%24.24%23.68%22.81%10.26%10.28%8.76%8.48%8.72%8.82%8.78%8.16%8.06%11.53%11.13%10.76%11.78%11.12%11.78%11.68%12.09%11.93%11.02%10.96%
Operating Expense015.59M25.59M20.31M31.90M24.75M55.26M15.63M1.48M55.39M437.67M421.01M426.93M351.83M331.46M480.21M537.77M548.24M676.71M815.87M947.26M887.00M1.08B1.15B3.13B3.03B2.98B3.41B4.04B4.86B6.03B6.58B6.54B7.62B6.37B
Operating Income62.38M26.67M38.35M34.25M25.77M37.82M-28.02M10.25M33.45M-16.93M24.67M-7.60M4.76M21.43M41.69M101.42M169.33M184.30M251.94M322.90M387.07M694.84M645.01M781.49M1.23B1.56B1.46B1.67B1.83B2.16B1.95B2.31B2.47B573.48M1.47B
Operating Margin100.00%31.56%32.10%26.57%15.99%24.94%-33.11%11.59%37.08%-15.69%1.48%-0.41%0.27%1.36%2.55%1.79%2.46%2.20%2.30%2.47%2.56%3.86%3.04%3.26%3.27%3.78%3.55%3.87%3.47%3.63%2.86%3.14%3.27%0.77%2.06%
EBITDA62.38M26.53M-25.62M28.42M27.63M30.28M-30.03M-15.75M4.67M10.54M64.38M34.24M44.33M53.57M61.23M159.72M253.78M303.48M376.65M502.15M628.07M854.89M940.44M1.09B1.57B1.89B1.70B1.98B2.25B2.58B2.47B2.82B4.15B1.06B1.47B
EBITDA Margin100.00%31.39%-21.45%22.05%17.14%19.96%-35.49%-17.81%5.18%9.77%3.86%1.83%2.49%3.40%3.74%2.82%3.69%3.63%3.44%3.84%4.15%4.75%4.44%4.54%4.15%4.58%4.12%4.59%4.27%4.33%3.61%3.84%5.49%1.42%2.06%
Net Income13.96M20.68M32.66M36.02M23.33M40.54M-29.73M14.12M20.59M-1.78M36.52M4.92M15.19M27.25M35.77M72.56M124.91M154.81M192.71M261.12M330.31M475.79M520.49M652.50M927.61M1.19B1.06B1.21B1.27B1.40B1.34B1.49B1.60B642.49M1.11B
Net Income Margin22.37%24.47%27.34%27.95%14.47%26.73%-35.13%15.96%22.83%-1.65%2.19%0.26%0.85%1.73%2.19%1.28%1.82%1.85%1.76%2.00%2.18%2.64%2.46%2.72%2.45%2.88%2.56%2.81%2.40%2.35%1.96%2.02%2.12%0.86%1.55%
R&D-------------------52.83M63.52M79.36M79.43M81.22M73.15M43.73M084.12M--7.74M9.07M26.82M24.55M19.99M
R&D as % of Total Revenue-------------------0.40%0.42%0.44%0.37%0.34%0.19%0.11%0.00%0.20%--0.01%0.01%0.04%0.03%0.03%
Interest Expense-732.43K2.23M-579.99K1.31M5.66M8.91M1.05M4.26M16.44M14.62M11.55M6.52M304.02K23.41M28.75M55.15M47.08M77.24M128.43M155.25M194.27M164.74M186.11M174.92M169.29M245.34M309.46M281.95M288.04M261.91M248.38M258.30M194.50M
Interest Expense % of Total Revenue-0.87%1.86%-0.36%0.86%6.69%10.07%1.16%3.95%0.99%0.78%0.65%0.41%0.02%0.41%0.42%0.66%0.43%0.59%0.85%0.86%0.92%0.69%0.49%0.42%0.41%0.57%0.59%0.47%0.42%0.36%0.33%0.35%0.27%

Balance Sheet

Currency: CNY1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-188.93M384.07M379.76M380.21M446.60M495.82M562.36M538.95M490.89M1.12B1.05B1.01B846.19M1.07B2.68B2.91B3.68B5.23B6.31B7.67B9.30B11.06B12.83B13.22B21.31B22.34B28.93B33.52B39.59B42.78B42.62B47.57B47.56B49.10B
Total Liabilities-93.14M96.88M56.85M50.55M89.48M167.66M114.11M86.72M85.83M753.72M717.90M665.47M487.99M678.73M2.21B2.39B3.03B4.36B5.18B6.24B7.46B8.74B7.98B7.65B12.40B12.42B15.02B18.16B22.71B24.76B23.17B26.59B26.80B27.47B
Total Equity-95.78M287.19M322.91M328.67M356.66M326.51M340.63M341.68M322.99M354.01M333.34M341.58M358.20M393.72M447.73M484.11M627.99M822.67M1.05B1.35B1.78B2.24B4.76B5.45B8.45B9.40B11.62B12.81B13.95B14.92B16.13B17.41B17.67B18.61B
Cash-64.01M99.19M72.12M63.79M62.37M92.51M118.21M89.51M43.34M158.88M109.15M163.50M80.87M169.29M205.34M254.83M345.26M579.47M711.79M952.67M953.99M1.11B867.56M1.57B3.52B4.19B8.09B8.88B6.00B5.13B6.02B6.50B7.41B7.80B
Total Debt-74.30M50.58M37.77M15.80M48.40M95.33M69.56M48.29M52.63M240.31M172.16M192.35M12.50M10.00M394.71M332.12M466.67M1.00B1.01B1.96B1.84B2.75B1.56B1.29B1.55B1.60B2.64B3.24B3.70B4.23B3.52B4.06B4.39B-
Net Debt-10.29M-48.61M-34.35M-47.99M-13.96M2.82M-48.65M-41.22M9.29M81.43M63.00M28.85M-68.37M-159.29M189.36M77.28M121.41M424.72M293.69M1.00B887.15M1.64B694.09M-279.81M-1.97B-2.59B-5.45B-5.65B-2.30B-900.30M-2.50B-1.42B-3.02B-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.21M22.84M8.52M71.16M28.76M81.22M130.30M148.28M181.73M87.70M246.58M270.85M428.16M227.32M323.96M465.03M-796.70M1.05B1.47B1.29B1.32B2.00B1.50B1.66B2.56B2.94B3.27B1.64B
Investing Cash Flow-16.85M-29.88M-50.21M73.63M-25.82M-43.89M-12.12M-83.35M-128.84M-13.35M-88.45M-156.47M-288.78M-211.23M-189.82M-131.24M-315.36M-135.14M-9.14M-286.18M-222.46M-240.45M-2.78B-455.53M-342.82M-135.43M-150.69M-
Financing Cash Flow35.80M-21.56M-4.48M-29.25M-52.67M17.02M-182.98M23.49M-16.83M-25.93M-68.84M77.24M-39.25M208.66M-121.28M-156.57M868.31M-197.83M-476.24M-477.02M2.86B-969.17M-1.74B-1.87B-1.51B-2.41B-1.83B-
Capital Expenditure10.38M27.54M21.01M35.91M26.90M49.36M14.18M50.62M118.22M71.41M84.98M102.94M177.99M198.97M193.57M150.50M342.67M190.36M265.89M204.35M255.48M245.17M293.83M370.43M322.19M322.21M282.70M217.35M
Free Cash Flow-5.17M-4.70M-12.49M35.25M1.87M31.86M116.11M97.65M63.51M16.29M161.60M167.91M250.17M28.35M130.38M314.53M-1.14B857.62M1.21B1.08B1.07B1.76B1.21B1.28B2.24B2.61B2.99B1.42B
Dividends Paid14.92M4.10M8.48M16.44M14.62M12.29M6.88M308.14K49.13M61.34M50.58M82.54M106.60M138.46M184.00M217.33M210.67M178.50M246.70M246.17M273.83M493.06M549.91M610.54M574.19M559.07M603.77M386.29M
FCF to OCF-99.33%-20.58%-146.65%49.54%6.49%39.23%89.11%65.86%34.95%18.57%65.54%61.99%58.43%12.47%40.25%67.64%143.01%81.84%81.94%84.10%80.68%87.74%80.45%77.62%87.42%89.03%91.36%86.74%
Dividend Paid to FCF-288.35%-87.24%-67.89%46.63%782.98%38.57%5.92%0.32%77.35%376.62%31.30%49.16%42.61%488.47%141.12%69.10%-18.49%20.81%20.44%22.77%25.66%28.09%45.49%47.52%25.65%21.38%20.20%27.18%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Nov 30, 2011Mar 26, 2012May 30, 2012Aug 29, 2012Nov 28, 2012May 29, 2013Aug 28, 2013Nov 27, 2013May 28, 2014Aug 15, 2014Oct 24, 2014Mar 20, 2015Apr 23, 2015Aug 19, 2015Oct 23, 2015Mar 26, 2016Apr 22, 2016Aug 17, 2016Oct 21, 2016Apr 28, 2017Aug 23, 2017Oct 25, 2017Mar 21, 2018Apr 23, 2018Aug 23, 2018Oct 26, 2018Apr 24, 2019Aug 23, 2019Oct 23, 2019Mar 24, 2020Apr 24, 2020Aug 28, 2020Oct 21, 2020Apr 1, 2021Aug 17, 2021Oct 19, 2021Mar 15, 2022Apr 27, 2022Aug 19, 2022Oct 24, 2022Apr 17, 2023Aug 8, 2023Oct 26, 2023Apr 25, 2024Aug 28, 2024Oct 28, 2024Mar 18, 2025Apr 24, 2025Aug 30, 2025Oct 31, 2025Apr 30, 2026Aug 31, 2026
EPS Estimate---------------------------------------------------------------------
EPS Actual0.060.080.110.060.100.110.120.090.120.150.130.180.160.170.220.250.230.240.250.360.350.350.430.360.420.520.620.550.510.680.660.630.630.651.120.580.720.750.680.700.841.000.770.750.940.810.720.580.920.830.921.160.780.610.590.980.881.030.940.700.800.630.63-0.750.630.600.520.530.60
Surprise---------------------------------------------------------------------
Timing--------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-market----

Key Statistics & Ratios

Market Cap7.33B
Enterprise Value10.25B
Trailing P/E5.84
Forward P/E6.84
PEG Ratio22.85
Price / Sales0.10
Price / Book0.33
EPS2.05
Book Value36.02
Revenue (TTM)72.89B
Gross Profit (TTM)7.51B
EBITDA1.84B
Profit Margin1.48%
Operating Margin2.39%
Return on Equity4.93%
Return on Assets2.10%
Shares Outstanding78.49M
Shares Float261.41M
Beta0.10
Dividend Yield5.89%
Dividend Rate0.71
Payout Ratio42.81%

Dividends

20261×
0.71Jun 24, 2026
20251×
0.36Jun 25, 2025
20241×
0.68Jun 25, 2024
20231×
0.82Jun 1, 2023
20221×
0.51Jun 17, 2022
20211×
0.67Jun 21, 2021
20201×
0.46Jun 18, 2020
20191×
0.32Jun 19, 2019
20181×
0.26Jun 13, 2018
20171×
0.23Jun 20, 2017
20161×
0.25May 30, 2016
20151×
0.16May 22, 2015
20141×
0.16May 28, 2014
20131×
0.16Jun 7, 2013
20121×
0.11Jun 19, 2012
20111×
0.10Jun 16, 2011
20101×
0.08Jun 17, 2010
20091×
0.08Jun 10, 2009
20071×
0.06Jul 10, 2007
20061×
0.03Jul 13, 2006
19971×
0.04Jul 29, 1997
19961×
0.02Jul 16, 1996
19951×
0.01Sep 1, 1995
19941×
0.01Aug 31, 1994

Stock Splits

  • Jun 24, 20261.1:1
  • Jun 1, 20231.3:1
  • Sep 11, 20001.8:1
  • Nov 12, 19961.2:1
  • Jul 16, 1996105:100
  • Sep 1, 199511:10
  • Aug 31, 199411:10